Company intelligence / Profile preview
Epitech Group
Milan, Lombardy, Italyepitech.it ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Epitech Group is an active Italian biological pharmacology company specializing in the development, production, and sale of advanced and novel therapy systems. The company's R&D is focused on identifying new mechanisms for modulation pharmacology to address nervous system disorders. Specific clinical results are not publicly detailed.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
27 assets26 more assets in the full pipeline.
Beyond the preview
Go deeper on Epitech Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epitech Group.